Rad26 Inhibitors belong to a distinct chemical class of compounds that have been the subject of scientific exploration for their potential to selectively modulate the activity of the Rad26 protein. Also known as Cockayne syndrome protein B (CSB), Rad26 plays a crucial role in DNA repair processes, particularly in transcription-coupled nucleotide excision repair. This repair mechanism is essential for removing various DNA lesions caused by environmental factors, thereby maintaining genomic integrity and cellular health. The chemical class of Rad26 inhibitors has been thoughtfully designed to interact with specific regions or binding sites within the Rad26 protein, aiming to influence its functional activity. By selectively engaging Rad26, these inhibitors have the potential to affect the efficiency and accuracy of DNA repair processes associated with transcription-coupled nucleotide excision repair.
The study of Rad26 inhibitors has garnered considerable interest due to its implications in understanding DNA repair pathways and their significance in maintaining genomic stability. Through in-depth investigations, researchers aim to unravel the intricate molecular mechanisms underlying Rad26's involvement in DNA repair processes. Moreover, the exploration of these inhibitors offers valuable insights into the broader context of DNA damage response and repair, facilitating a deeper understanding of cellular responses to genotoxic stress. However, it is essential to emphasize that the field of Rad26 inhibitors is still evolving, and further research is required to fully elucidate the precise mechanisms of action and potential selectivity of these compounds for Rad26. As with any active area of research, continued exploration of Rad26 inhibitors holds promise in expanding our knowledge of DNA repair pathways and may inspire novel strategies to manipulate cellular responses to DNA damage.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
A topoisomerase II inhibitor that induces DNA damage and is known to affect DNA repair pathways. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
A platinum-based chemotherapy drug that forms DNA adducts, leading to DNA damage and repair responses. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
An inhibitor of poly(ADP-ribose) polymerase (PARP), which plays a role in base excision repair. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $178.00 $270.00 $712.00 | 3 | |
Another PARP inhibitor that affects DNA repair processes. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $350.00 | 10 | |
A specific DNA-PK inhibitor. | ||||||
NU 1025 | 90417-38-2 | sc-203166 | 5 mg | $131.00 | 9 | |
An inhibitor of the DNA repair enzyme poly(ADP-ribose) glycohydrolase (PARG). | ||||||
RAD51 Inhibitor B02 | 1290541-46-6 | sc-507533 | 10 mg | $95.00 | ||
An inhibitor of Werner helicase (WRN), a protein implicated in DNA repair. | ||||||